Marina
Pollán Santamaría
Publicaciones en las que colabora con Marina Pollán Santamaría (10)
2005
-
Variación del valor pronóstico de la proteína p53 en relación con el estadio tumoral en pacientes con adenocarcinoma colorrectal
Cirugia Espanola, Vol. 77, Núm. 4, pp. 213-220
2003
-
Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer
International Journal of Cancer, Vol. 107, Núm. 5, pp. 781-790
2000
-
Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma
Cancer, Vol. 88, Núm. 1, pp. 35-41
1998
-
Histopathologic prognostic score in colorectal adenocarcinomas
Anticancer Research, Vol. 18, Núm. 1 B, pp. 689-694
1997
-
Prediction of recurrence by quantification of p185(neu) protein in non-small cell lung cancer tissue
British Journal of Cancer, Vol. 75, Núm. 5, pp. 684-689
1996
-
Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer
British Journal of Cancer, Vol. 73, Núm. 10, pp. 1248-1254
1995
-
Concordance between serum and cytosolic levels of CEA CA125 and SCC antigens in patients with non-small cell lung cancer
Anticancer Research, Vol. 15, Núm. 6 B, pp. 2811-2817
1994
-
Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma
Anticancer Research, Vol. 14, Núm. 6 B, pp. 2819-2825
-
Prognostic significance of serum ca 125 antigen assay in patients with non‐small cell lung cancer
Cancer, Vol. 73, Núm. 5, pp. 1368-1376
1993
-
UTILIDAD DEL ANTIGENO CA 125 EN SUERO COMO FACTOR PRONOSTICO DE SUPERVIVENCIA EN PACIENTES CON CARCINOMA PULMONAR NO MICROCITICO
Neoplasia, Vol. 10, Núm. 6, pp. 192-196